Cabaletta Bio, Inc. (CABA) Stock Grade

About Cabaletta Bio, Inc.'s fundamentals

Cabaletta Bio is a biotechnology company with a market capitalization of $224.0 million that reported no revenue growth year-over-year and generated no net income in its latest annual period. The company is currently unprofitable, with a net loss reported in its latest annual statement, and does not pay dividends to shareholders. As a pre-revenue or early-stage biotech firm, traditional profitability metrics like P/E ratio and return on equity are not applicable, which is typical for companies in development-stage phases focused on research and product development.